news_6

CORRECTING and REPLACING First Patient Dosed in CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Remove sixth paragraph of release: (Class 1 new drug refers to new chemical entities, demonstrating clinical...

news_6

CORRECTING and REPLACING First Patient Dosed in CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Remove sixth paragraph of release: (Class 1 new drug refers to new chemical entities, demonstrating clinical...

news_6

Australia Prepaid Cards Markets and Investment Opportunities Report 2021: Market is Expected to Grow by 12.7% to Reach $22.32 Billion in 2021 – Forecast to 2025 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Prepaid Cards Business and Investment Opportunities - Market Size and Forecast (2016-2025), Consumer Attitude & Behaviour, Retail...

news_6

China Prepaid Card Markets and Investment Opportunities Report 2021: Market is Expected to Grow by 10.6% to Reach $326,409.3 Million in 2021 – Forecast to 2025 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "China Prepaid Cards Business and Investment Opportunities - Market Size and Forecast (2016-2025), Consumer Attitude & Behaviour, Retail...